Skip to content

INFIBIO

Active Private limited companyfounded 2018active for 8 yearsLakense Laan 37, 1090 JetteKBO/BCE: BE 0688.578.353

Lifetime

8 annual accounts with figures on one time axis
peak of €81,252 in 2023
€18,324▲ €40,337
lowest -€26,188 in 2024
€12,971▲ €39,159
peak of €161,466 in 2023
€129,369▼ 4.4%
€26,450▼ 61.0%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
09-09-202640 days late
2025micro format
Gross margin from -€22,013 to €18,324Profit of €12,971, after a lossDividend €18,880Debts from €67,777 to €26,450

Key points

from the 2025 annual accounts

Equity

€129,369 ▼ 4.4%
135,2782024+12,971Profit-18,880Dividend129,3692025

INFIBIO paid out €18,880 in dividends. That is 146% of the 2025 profit.

Liquidity

5.58 was 2.82 in 2024

Short-term debts fell from €67,777 to €26,450.

Filings

8 annual accounts 7 late
AprilJune31 JulyOctober20202025

The 2024 accounts came in latest, 421 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,977 companies had the same profile as INFIBIO has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,977 companies, not a prediction for INFIBIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • founderdeed of 19-01-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0688578353
Registered office moved within Brussels The registered office moved from Anderlecht (1070 Bruxelles) rue Foppens, 9 to Jette (1090 Bruxelles) avenue de Laeken 37 · resigns as manager · reappointed as director · General meeting of 24-07-2024 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €12,400 paid up · Founded by (comparant) · appointed as manager · published on 19-01-2018 · Gazette deed
First establishment Foppensstraat 9, Anderlecht
All 20 events

Official details

Source: KBO
Status
Active since 17-01-2018Normal situation
Activity
Nursing and midwiferyNACE 869401 activity on the establishment unitFrom the articles, 7 activities
Establishment unit
2.272.889.8451070 Anderlecht, since 17-01-2018
Financial year end
31 December
Peppol
Reachable since 07-07-2026
Company details

Annual accounts 2025

≈ €140,000estimated
€155,819▼ 23.3%
Filing
Filed on 09-09-2026
Financials

Insights on INFIBIO

INFIBIO files the micro format. That format states no turnover. The gross margin rose from €8,596 in 2018 to €18,324 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INFIBIO

What is the company number of INFIBIO?
The company number of INFIBIO is 0688.578.353. The VAT number is the same number with BE in front: BE 0688.578.353.
Where is INFIBIO based?
The registered office is at Lakense Laan 37, 1090 Jette.Company details
What does INFIBIO do?
According to the KBO register, the main activity of the establishment unit is nursing and midwifery (NACE 86940).
What is the legal form of INFIBIO?
INFIBIO is a private limited company (BV).
When was INFIBIO founded?
INFIBIO was founded on 17-01-2018.
Is INFIBIO still active?
Yes, INFIBIO is an active enterprise in the KBO register.
What is the turnover of INFIBIO?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €18,324 and 7,100 comparable companies of the same size. It probably lies between €62,000 and €320,000. It is a rough estimate.Financials
Is INFIBIO profitable?
In financial year 2025, INFIBIO made a profit of €12,971.
Where can I find the annual accounts of INFIBIO?
INFIBIO filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INFIBIO due?
INFIBIO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.